Please login to the form below

Not currently logged in
Email:
Password:

CicloMulsion

This page shows the latest CicloMulsion news and features for those working in and with pharma, biotech and healthcare.

Sanofi licenses cardiovascular therapy in South Korea

Sanofi licenses cardiovascular therapy in South Korea

The deal - signed by Sanofi's Asian subsidiary and covering only the South Korean market - covers a new formulation of cyclophilin inhibitor cyclosporine A - called CicloMulsion - that is in phase III ... NeuroVive's chief executive Mikael Brönnegård

Latest news

  • inVentiv extends collaboration with NeuroVive inVentiv extends collaboration with NeuroVive

    The new deal will see consultancy firm InVentiv assist NeuroVive with the global commercialisation of its lead product, CicloMulsion, which is currently in phase III trials to determine its effectiveness in ... NeuroVive and inVentiv are already

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals during November 2012 Pharma deals during November 2012

    8. Sihuan Pharmaceutical / NeuroVive Pharmaceutical. Collaboration agreement. CicloMulsion / NeuroSTAT to treat heart reperfusion / traumatic brain injuries. ... Canadian research facility.  South Korea market.  Pursuant to the collaboration agreement,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics